Quantitative in vitro screening methods are essential in drug development for measuring the hematotoxicity of novel candidates on normal and malignant hematopoietic stem and progenitor cells (HSPCs). However, these methods can be challenging and resource intensive. Explore our collection of protocols and tech tips for information on how to efficiently measure hematotoxicity with easy-to-use liquid culture-based assays.
StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not
share your email address with third parties. StemCell Technologies Inc. will use your email address to
confirm your identity and send you newsletters, transaction-related emails, promotional and customer
your email preferences at any time.